[Behavior of serum lipids, blood coagulation factors, platelet aggregation, complement and serum immunoglobulins in a group of arteriosclerotic, hyperlipemic subjects treated with 3GS].
作者信息
D'Eredità F, Avellone G, Novo S, Davì G, Abruzzese G, Di Liberti M, Pinto A, Riolo F
出版信息
Clin Ter. 1981 Feb 15;96(3):303-24.
PMID:7307448
Abstract
摘要
相似文献
1
2
Preliminary results of sulodexide treatment in patients with peripheral arteriosclerosis and hyperlipidemia. A multicentre trial.
Monogr Atheroscler. 1986;14:215-21.
3
[Long-term effects of a glycosaminoglycan on plasma lipids].[一种糖胺聚糖对血脂的长期影响]
Clin Ter. 1981 Jul 15;98(1):47-61.
4
[The clinico-biochemical activity and tolerance of the hypolipidemic preparation lipanthyl].
Ter Arkh. 1991;63(8):61-4.
5
[Rapid changes in blood lipid parameters induced by glucuronyl glucosamine glycan sulfate in obese diabetic and hyperlipidemia patients].[硫酸葡糖醛酸氨基葡糖聚糖对肥胖糖尿病和高脂血症患者血脂参数的快速影响]
Arch Sci Med (Torino). 1982 Oct-Dec;139(4):441-8.
6
[Platelet aggregation in whole blood and thromboxane B2 in type II and IV hyperlipidemia].
Minerva Med. 1987 Dec 15;78(23):1739-43.
7
[Platelet aggregation in whole blood and prostacyclin in hyperlipemia types II and IV].
Minerva Med. 1988 May;79(5):349-54.
8
[Evaluation of a sulfomucopolysaccharide (3GS) in the treatment of hyperlipoproteinemias].[一种硫代粘多糖（3GS）治疗高脂蛋白血症的评估]
Clin Ter. 1982 Jun 30;101(6):603-14.
9
[Clearing and anti-platelet-aggregation effects of a heparinoid of natural origin].
Clin Ter. 1974 Oct 15;71(1):13-31.
10
Zotero 插件